1 false false false false false false false false false false true false false false false false false No description of principal activity 2024-05-01 Sage Accounts Production Advanced 2025 - FRS102_2025 xbrli:pure xbrli:shares iso4217:GBP 14828489 2024-05-01 2025-04-30 14828489 2025-04-30 14828489 2024-04-30 14828489 2023-04-26 2024-04-30 14828489 2024-04-30 14828489 2023-04-25 14828489 bus:Director1 2024-05-01 2025-04-30 14828489 core:WithinOneYear 2025-04-30 14828489 core:WithinOneYear 2024-04-30 14828489 core:RetainedEarningsAccumulatedLosses 2025-04-30 14828489 core:RetainedEarningsAccumulatedLosses 2024-04-30 14828489 bus:SmallEntities 2024-05-01 2025-04-30 14828489 bus:AuditExemptWithAccountantsReport 2024-05-01 2025-04-30 14828489 bus:SmallCompaniesRegimeForAccounts 2024-05-01 2025-04-30 14828489 bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 14828489 bus:FullAccounts 2024-05-01 2025-04-30
COMPANY REGISTRATION NUMBER: 14828489

Amber Masterson Neuro SLT Limited

Filleted Unaudited Financial Statements

30 April 2025

Amber Masterson Neuro SLT Limited

Statement of Financial Position

30 April 2025

| 2025 | 2024
Note | £ | £ | £

Current assets

Debtors | 5 | 4,847 |  | 7,710
Cash at bank and in hand | 404 |  | 7,478
| ------- |  | --------
| 5,251 |  | 15,188

Creditors: amounts falling due within one year | 6 | 3,184 |  | 12,814
| ------- |  | --------
Net current assets |  | 2,067 | 2,374
|  | ------- | -------
Total assets less current liabilities |  | 2,067 | 2,374
|  | ------- | -------
Net assets |  | 2,067 | 2,374
|  | ------- | -------

Capital and reserves

Profit and loss account |  | 2,067 | 2,374
|  | ------- | -------
Shareholders funds |  | 2,067 | 2,374
|  | ------- | -------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 1 December 2025 , and are signed on behalf of the board by:

A R Masterson |
Director |

Company registration number: 14828489

Amber Masterson Neuro SLT Limited

Notes to the Financial Statements

Year ended 30 April 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 40 Kimbolton Road, Bedford, MK40 2NR, Beds.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of it's liabilities.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2024: 1 ).
5. Debtors

| 2025 | 2024
| £ | £
Trade debtors | 739 | 7,675
Other debtors | 4,108 | 35
| ------- | -------
| 4,847 | 7,710
| ------- | -------

6. Creditors: amounts falling due within one year

| 2025 | 2024
| £ | £
Corporation tax | 1,219 | 7,081
Social security and other taxes | 241 | 247
Other creditors | 1,724 | 5,486
| ------- | --------
| 3,184 | 12,814
| ------- | --------

7. Director's advances, credits and guarantees
As at 30th April 2025, the directors loan account was over drawn by £4,108 (2024 £nil). this was repaid within nine months of the year end,